Genomatica completes 90 M$ financing and strengthens partnership with Ginkgo Bioworks



Type of post: FLASH NEWS.

- Genomatica has just announced that it has issued 90 M$ in its latest equity offering, strengthening its balance sheet to fully execute on its business plan and fuel new growth opportunities.
- Main participants: Casdin Capital (new lead investor), Viking Global (returning investor and largest shareholder) and Ginkgo Bioworks (organism engineering partner).
- Genomatica have also announced that it is extending its relationship with Ginkgo to accelerate biotechnology innovations for widely-used chemicals. Ginkgo will now provide expanded access to their foundry capabilities and services, while increasing its equity stake in Genomatica.
Related posts:

Figure 1. Genomatica strengthens partnership with Ginkgo Bioworks

Popular Posts

Biofuels from algae

Hidrotratamiento (HVO) – Conceptos, materias primas y especificaciones

Biorrefinerías de ácido levulínico

Etanol celulósico – Lo básico: Conceptos y materias primas

FDCA (2,5-furandicarboxylic acid) biorefineries